Sign in

CIK 0000882796

  • Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
621413174
Phone
+1 919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-11 SANDERS MACHELLE Director Grant or award +15,294 45,936
2026-06-11 SANDERS MACHELLE Director Grant or award · Automatic Stock Option Grant +33,540 33,540
2025-11-13 SANDERS MACHELLE Director Sale 10b5-1 −9,600 $7.14 $69K 30,642
2025-06-12 SANDERS MACHELLE Director Grant or award +12,500 40,242
2025-06-12 SANDERS MACHELLE Director Grant or award · Automatic Stock Option Grant +27,181 27,181
2024-06-17 SANDERS MACHELLE Director Sale −4,689 $6.00 $28K 27,742
2024-06-12 SANDERS MACHELLE Director Grant or award +6,820 32,431
2024-06-12 SANDERS MACHELLE Director Grant or award · Automatic Stock Option Grant +49,933 49,933
2023-06-15 SANDERS MACHELLE Director Sale −4,000 $7.98 $32K 25,611
2023-06-13 SANDERS MACHELLE Director Grant or award +16,745 29,611
2023-06-13 SANDERS MACHELLE Director Grant or award · Automatic Stock Option Grant +39,072 39,072
2022-06-07 SANDERS MACHELLE Director Grant or award +12,866 12,866
2022-06-07 SANDERS MACHELLE Director Grant or award · Automatic Stock Option Grant +30,022 30,022
2022-02-08 SANDERS MACHELLE Director Grant or award · Non-Qualified Stock Option +26,667 26,667

Page 1 of 1 · 14 trades